Table 2.
Endocan and VEGF levels according to Child–Pugh score among HCC group and cirrhosis group Table 2 Endocan and VEGF levels according to Child–Pugh score among HCC group and cirrhosis group
| Child– Pugh | n | Endocan (pg/mL) | KWT and P | VEGF (pg/mL) | KWT and P | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | ± SD | Minimum | Maximum | Mean | ± SD | Minimum | Maximum | ||||
| Endocane and VEGF levels according to Child–Pugh score among HCC group | |||||||||||
| A | 45 | 3396.0 | 223.3 | 3145.0 | 3840.0 | 78.4 and <0.001 (HS) | 2605.6 | 1772.2 | 714.6 | 4825.0 | 3.98 and 0.13 |
| B | 39 | 4333.6* | 888.7 | 1432.0 | 4785.0 | 2091.3 | 1573.4 | 621.0 | 5104.0 | ||
| C | 21 | 5486.2*,^ | 181.6 | 5175.0 | 5708.0 | 1436.7 | 1226.3 | 749.4 | 4105.0 | ||
| Endocan and VEGF levels according to Child–Pugh score among cirrhosis group. | |||||||||||
| A | 3 | 1516.0 | 0.0 | 1516.0 | 1516.0 | 38.1 and <0.001 (HS) | 488.0 | – | 488.0 | 488.0 | 5.76 and 0.056 (NS) |
| B | 27 | 1869.4 | 1056.1 | 4768.0 | 4768.0 | 3694.6 | 6777.1 | 58.0 | 22344.0 | ||
| C | 60 | 2398.5*,^ | 164.0 | 2789.0 | 2789.0 | 3510.8 | 6482.6 | 263.0 | 22344.0 | ||
Notes:
*
Significant in comparison with A,
^
Significant in comparison with B.
Abbreviations: HCC, hepatocellular carcinoma; HS, highly significant; KWT, Kruskal–Wallis test; VEGF, vascular endothelial growth factor.